In leukemia, there is a population of cells, known as leukemia stem cells, that are resistant to treatment that works on other leukemia cells. Scientists are investigating the use of drugs that can specifically identify and then kill these leukemia stem cells. In essence, this type of therapy might not be classified as a stem cell therapy, but rather a therapy that treats a disease caused by stem cells.